Document is current
Any future updates will be listed below
-
Authors
Larsson, Ida https://orcid.org/0000-0001-5422-4243
Dalmo, Erika https://orcid.org/0000-0003-0272-9893
Elgendy, Ramy https://orcid.org/0000-0002-2592-3448
Niklasson, Mia https://orcid.org/0000-0001-8192-347X
Doroszko, Milena https://orcid.org/0000-0001-6844-9523
Segerman, Anna https://orcid.org/0000-0002-5070-7587
Jörnsten, Rebecka
Westermark, Bengt https://orcid.org/0000-0001-7153-5545
Nelander, Sven https://orcid.org/0000-0003-1758-1262
-
Funding
Funding for this research was provided by:
Cancerfonden
Barncancerfonden
Vetenskapsrådet
Swedish Foundation for Strategic Research
- License Information
-
More Information
Article History
Received: 13 November 2020
Revised: 16 August 2021
Accepted: 17 August 2021
First Online: 16 September 2021
Conflict of interest
: The authors declare no conflict of interest. RE is presently an AstraZeneca employee.
